NM_006009.4:c.966C>T

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_006009.4(TUBA1A):​c.966C>T​(p.Asp322Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00329 in 1,614,066 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0025 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0034 ( 16 hom. )

Consequence

TUBA1A
NM_006009.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.53

Publications

4 publications found
Variant links:
Genes affected
TUBA1A (HGNC:20766): (tubulin alpha 1a) Microtubules of the eukaryotic cytoskeleton perform essential and diverse functions and are composed of a heterodimer of alpha and beta tubulins. The genes encoding these microtubule constituents belong to the tubulin superfamily, which is composed of six distinct families. Genes from the alpha, beta and gamma tubulin families are found in all eukaryotes. The alpha and beta tubulins represent the major components of microtubules, while gamma tubulin plays a critical role in the nucleation of microtubule assembly. There are multiple alpha and beta tubulin genes, which are highly conserved among species. This gene encodes alpha tubulin and is highly similar to the mouse and rat Tuba1 genes. Northern blot studies have shown that the gene expression is predominantly found in morphologically differentiated neurologic cells. This gene is one of three alpha-tubulin genes in a cluster on chromosome 12q. Mutations in this gene cause lissencephaly type 3 (LIS3) - a neurological condition characterized by microcephaly, intellectual disability, and early-onset epilepsy caused by defective neuronal migration. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2017]
TUBA1B-AS1 (HGNC:56356): (TUBA1B antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 12-49185400-G-A is Benign according to our data. Variant chr12-49185400-G-A is described in ClinVar as Benign. ClinVar VariationId is 160165.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.53 with no splicing effect.
BS2
High AC in GnomAd4 at 379 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TUBA1ANM_006009.4 linkc.966C>T p.Asp322Asp synonymous_variant Exon 4 of 4 ENST00000301071.12 NP_006000.2 Q71U36-1
TUBA1ANM_001270399.2 linkc.966C>T p.Asp322Asp synonymous_variant Exon 4 of 4 NP_001257328.1 Q71U36-1
TUBA1ANM_001270400.2 linkc.861C>T p.Asp287Asp synonymous_variant Exon 4 of 4 NP_001257329.1 Q71U36-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TUBA1AENST00000301071.12 linkc.966C>T p.Asp322Asp synonymous_variant Exon 4 of 4 1 NM_006009.4 ENSP00000301071.7 Q71U36-1

Frequencies

GnomAD3 genomes
AF:
0.00249
AC:
379
AN:
152158
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000507
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00164
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00373
Gnomad FIN
AF:
0.00396
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00376
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00250
AC:
625
AN:
250424
AF XY:
0.00256
show subpopulations
Gnomad AFR exome
AF:
0.000700
Gnomad AMR exome
AF:
0.00124
Gnomad ASJ exome
AF:
0.00169
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00365
Gnomad NFE exome
AF:
0.00333
Gnomad OTH exome
AF:
0.00261
GnomAD4 exome
AF:
0.00338
AC:
4935
AN:
1461790
Hom.:
16
Cov.:
30
AF XY:
0.00339
AC XY:
2465
AN XY:
727196
show subpopulations
African (AFR)
AF:
0.000448
AC:
15
AN:
33472
American (AMR)
AF:
0.00145
AC:
65
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00218
AC:
57
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00228
AC:
197
AN:
86254
European-Finnish (FIN)
AF:
0.00363
AC:
194
AN:
53420
Middle Eastern (MID)
AF:
0.00156
AC:
9
AN:
5758
European-Non Finnish (NFE)
AF:
0.00379
AC:
4212
AN:
1111950
Other (OTH)
AF:
0.00308
AC:
186
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
427
853
1280
1706
2133
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
158
316
474
632
790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00249
AC:
379
AN:
152276
Hom.:
3
Cov.:
32
AF XY:
0.00247
AC XY:
184
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.000505
AC:
21
AN:
41566
American (AMR)
AF:
0.00164
AC:
25
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00373
AC:
18
AN:
4824
European-Finnish (FIN)
AF:
0.00396
AC:
42
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00376
AC:
256
AN:
68020
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
21
42
64
85
106
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00264
Hom.:
0
Bravo
AF:
0.00200
EpiCase
AF:
0.00300
EpiControl
AF:
0.00314

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Nov 07, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 10, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TUBA1A: BP4, BP7, BS1, BS2 -

not specified Benign:1
Oct 31, 2016
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
1.1
DANN
Benign
0.86
PhyloP100
-1.5
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142641191; hg19: chr12-49579183; COSMIC: COSV55497677; COSMIC: COSV55497677; API